Two insiders bought $7,210,233 of Electra Therapeutics, Inc. shares between 3 Nov and 5 Nov
Open-market purchases reported on SEC Form 4: Carl L Gordon (Director) $3,605,116; ORBIMED ADVISORS LLC (Director) $3,605,116.
Written and published automatically by the Loro Intelligence Engine from public records. No editor reviewed this before publication.
Two insiders at Electra Therapeutics, Inc. (ETRA) bought shares worth a combined $7,210,233 on the open market between 3 Nov 2026 and 5 Nov 2026, according to Form 4 filings with the US Securities and Exchange Commission.
- Combined purchases
- $7,210,233
- Buyers
- 2
- Period
- 3 Nov 2026 and 5 Nov 2026
- Source
- SEC Form 4 filings
Two insiders at Electra Therapeutics, Inc. (ETRA) bought shares worth a combined $7,210,233 on the open market between 3 Nov 2026 and 5 Nov 2026, according to Form 4 filings with the US Securities and Exchange Commission.
Carl L Gordon, Director, bought $3,605,116 of shares between 3 Nov 2026 and 5 Nov 2026.
ORBIMED ADVISORS LLC, Director, bought $3,605,116 of shares between 3 Nov 2026 and 5 Nov 2026.
The filings do not state the reasons for the purchases. Loro has made no approach to the company. Figures are as reported in Electra Therapeutics, Inc.'s SEC Form 4 filings.
Primary sources
2 recordsEvery factual claim above is drawn from these records. Each link resolves to the publisher’s own copy.